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Abstract
Many studies have been conducted to investigate synergism among insecticidal proteins; however, a consensus 
on minimal data requirements and interpretation is lacking. While some have concluded that all additive predictive-
type models should be abandoned, we advocate that additivity models can remain useful as assessment tools 
and that an appropriately designed interaction study will never systematically underestimate the existence of 
synergism, irrespective of which additivity model (or none at all) may be used. To generate the most meaningful 
synergy assessment datasets in support of safety assessments, we highlight two beneficial steps to follow: (i) 
select a testing model which is the most consistent with current knowledge regarding the action of the insecticidal 
proteins and (ii) avoid using bioassay methods which may result in excess response heterogeneity. We also outline 
other experimental design elements to consider, which may be crucial for conducting future studies of this type. 
A  contrast of underlying testing assumptions associated with the additivity models is provided, along with a 
comprehensive review of interaction data for Cry1, Cry2, Cry3, Cry9, and Vip3A insecticidal proteins. Our review 
captures four recurrent findings: i) experiments reporting synergistic interactions are a minority, ii) the degree of 
synergism reported is low in magnitude, iii) reported interactions are sometimes equivocal/inconclusive due to 
unconfirmed model assumptions or other bioassay challenges, and iv) due to biological response variation many of 
the reported interactions may be artefactual. A brief overview of the positioning of interaction testing data in safety 
assessments of GM food crops is also provided. 
Key words:  Bacillus thuringiensis, synergism, interaction, Cry, Vip
An increase in transgenic crop insecticidal protein combinations has 
given rise to an assessment of the potential antagonistic, synergistic, 
or potentiating toxicological interactions of the multiple proteins 
being included in a dossier in support of product registration (US 
EPA 2009a, Raybould et al. 2012a). Synergism or potentiation might 
be of benefit from a product standpoint, as active principles (e.g., 
insecticidal trait proteins, active ingredients) might then achieve 
higher levels of control. With regard to risk assessment, such an 
interaction might not introduce a new hazard concern per se (in 
many cases, individual agents will have already undergone a risk 
assessment), but would indicate that the hazard of the combination 
of agents to non-target organisms may be greater than the sum of 
the hazards of the individual agents. Antagonism, on the other hand, 
might mean that the potency of a combination of agents against tar-
get pests is less than that of the sum of the components, which may 
have adverse consequences for product efficacy and insect resistance 
management.
With regard to synergistic interactions for any two agents 
(not specific to insecticidal proteins), such occurrences have been 
described as rare in low-dose mixtures (i.e., using No Observable 
Effect Concentration [NOEC] doses in mammalian testing) and 
seldom has more than a 10-fold effect been observed (Cedergreen 
2014). Furthermore, an estimate of the likelihood of such occur-
rences may even be somewhat inflated due to reporting bias (Boobis 
et al. 2011, Cedergreen 2014).
Different experimental approaches have been put forth to con-
sider potential insecticidal protein interactions (Tabashnik 1992, 
Greenplate et  al. 2003, Raybould et  al. 2012a, Tabashnik et  al. 
2013, Levine et al. 2016, Graser et al. 2017), but they commonly 
rely on one of three models to interpret the additivity of tested com-
ponents (Table  1). Two of these somewhat related dose–response 
models, which have been utilized the most, have been termed ‘con-
centration addition’ (CA) or ‘response addition’ (RA), respectively. 
Implementation of the CA and RA models has been summarized and 
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contrasted in numerous reviews (e.g., Berenbaum 1989, Newman 
2013, Cedergreen 2014); and they are derived from original works 
of Loewe and Muischnek (1926) or Bliss (1939) for the CA or RA 
model approaches, respectively. A variation on these models, which 
involves consideration of a more dynamic or multidimensional sur-
face where the mode of action only appears to be similar or where 
the relative potency is not constant at all effect levels has been 
termed isobologram analysis (or a Combination Index) (Tallarida 
2001, Foucquier and Guedj 2015). Although it provides an inter-
esting approach, isobologram analysis quickly becomes extremely 
complex and has not yet been demonstrated to add much predictive 
function (Rodea-Palomares et al. 2015). It has not been utilized for 
insecticidal protein interaction testing and will not be considered 
further in this present review. The third most common model for 
insecticidal protein interaction testing is simply termed ‘Empirical’ 
as it is based on an empirical test of the response data following an 
interaction study using a combination of agents.
The CA model (alternatively named dose addition, simple simi-
lar action, similar joint action, or Loewe additivity) is based on the 
assumption that the toxicants have the same mode of action (MoA) 
at the target site and can be described as dilutions of each other, 
although perhaps with differing potencies (Table 1). The RA model 
(alternatively named Independent joint action, independent action, 
Bliss independence, or effect additivity) assumes the existence of a 
different molecular target for the toxicants, and that the two compo-
nents produce independent effects (from a probabilistic standpoint), 
leading to the actual mortalities (not the doses) being described as 
additive. Both additivity models have been routinely used to deter-
mine if an effect exceeds the expected amount for a combination of 
agents. Exactly what constitutes an ‘expected response,’ though, has 
been and continues to be the subject of much debate (Berenbaum 
1989, Berthoud 2013, Geary 2013, Cedergreen 2014, Sucher 2014, 
Foucquier and Guedj 2015). The Empirical testing model involves 
no real prerequisite assumptions, but for practical usage is limited to 
situations where one or more of the tested components are inactive 
(Table 1).
Some experimental similarities do exist between the RA and CA 
models. One situation is over a linear range of similar dose–response 
curves, where the RA model can routinely be considered equivalent 
to the CA model (Gennings et al. 2005, Price 2010); however, this is 
not the case in the subthreshold regions of the dose–response curves, 
where the RA model technically considers these doses as not contrib-
uting to an effect. For either model, a steeper slope can be interpreted 
as reflecting a more homogeneous population for the measured re-
sponse. Also applicable to either model, there can be a considerable 
challenge in reproducibly obtaining estimates of a single parameter 
(e.g., an LC50 obtained by probit analysis) to accurately describe the 
dose–responses. Due to inherent variation, several authors have rec-
ommended use of a built-in threshold of at least twofold above the 
predicted response for even considering a result as being more than 
additive (Belden et  al. 2007, Cedergreen 2014, Rodea-Palomares 
et al. 2015).
Related to the reproducibility challenge noted earlier, probit 
analysis (which is routinely used in insecticidal protein bioassay), 
is itself an estimation technique and admittedly a simplification 
of reality. In many ways, however, this analysis is well-suited to 
support the interaction assessment needs for insecticidal proteins. 
The assumptions for probit analysis are reasonable when used for 
binary type responses (e.g., living or dead, or meeting a defined 
response metric), which possess a sigmoidal response curve with 
probability constrained to be in the interval of 0–100% response 
(Gennings et  al. 2005); furthermore, the log-normal distribution 
(by dose) assumption is capable of confirmation by testing (e.g., 
passes a goodness-of-fit or heterogeneity test for the distribution). 
Table 1. Three common models used for interaction testing and interpretation of additivity of insecticidal proteins
Model Assumptions/requirements Model use/interpretation Experimental
Strengths Challenges Strengths Challenges
CAa Proteins have the same MoA
Dose–response has same upper 
threshold and same slope
A single relative potency factor 
applies for comparison of  
the dose-response of any  
two agents
Conservative from an 
ERA standpoint
Can be designed to 
assess doses in the 
active range
MoA may not always be  
a priori clearly defined/ 
established
Well-established, full dose– 
response data of a  
similar shape are 
prerequisite
Any uniform ratio  
of the combined 
agents could be 
selected for a given 
dose–response 
dataset
Requires full set of dose–
responses to generate 
comparison parameter 
(e.g., LC50)
RAb Proteins have different MoA
Dose–response has same  
upper threshold
Doses selected must have a  
measurable effect when each 
agent is presented alone
The most conserva-
tive from an ERA 
standpoint
By default, the design 
assesses doses in  
the active range
MoA may not always be  
a priori clearly defined/ 
established
Have to avoid testing at  
a sublethal dose
Minimal dose  
requirements  
(e.g., can work  
with as few as  
1 or 2 selected  
doses)
Requires parallel testing 
of individual agents at 
same selected dose(s)
Empiricalc One (or more) of the agents  
to be tested has no toxicity  
to the test organism
No direct relation  
to MoA 
interpretations
No need to calculate  
an expected  
response (e.g.,  
default expectation 
for one agent is  
zero activity)
If the agents act against  
the same target pest,  
establishing a nominal 
sublethal dose to use  
can be difficult
Minimal dose  
requirements  
(e.g., can work  
with as few as  
1 or 2 selected  
doses)
May require a larger data-
set for robust statistical 
analysis
aAlso known as dose addition, simple similar action, similar joint action, or Loewe additivity.
bAlso known as independent joint action, independent action, Bliss independence, or effect additivity.
cAlso known as simple empirical or simple statistical test.
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If these confirmations are intact, it is also reasonable to use a ‘frac-
tional product method’ additivity model (such as the RA model) 
to quantify and compare the median effect responses for a com-
bination of mutually non-exclusive agents, as the method approxi-
mates what would be seen for agents obeying the law of mass action 
(Berenbaum 1985). This method can also be reasonably extended to 
describe the probabilistic effects from insecticidal proteins (which 
are actually the manifestation of a series of different steps in the 
MoA, leading up to a single metric of the binary response) even 
though these are likely not truly derived from a single or predom-
inant mass action relation. It has been observed that these more 
complex series of responses as measured for insecticidal proteins 
may be better described as reflecting the distribution of sensitivi-
ties (Berenbaum 1989) to the protein agents. In contrast, responses 
which are non-binary (e.g., gradual/quantitative changes in growth, 
fecundity, behavior, degree of binding), may have differing maxi-
mal effects and, therefore, not be as suitable for probit analysis and 
would present an extra challenge to adoption of either a CA or RA 
additivity approach (Putzrath et al. 1997, Geary 2013).
The CA Model Requirement for a Parallel Slope if a 
Single Relative Potency Factor is Assumed
If one agent can truly perform as a mere dilution of a similarly act-
ing agent, then under the CA model, the shape (and slope) of the 
dose–response curve must be similar (statistically the same or at least 
parallel) (Berenbaum 1989, Villeneuve et al. 2000, Tallarida 2001, 
Cedergreen et al. 2008, Gennings 2010). Furthermore, the shape of 
this curve would not be expected to change in the presence of the 
other agent (Gennings et al. 2005). For these combinatorial analyses, 
it is important to compare doses over similar regions of the dose–
response relationship that were used to establish the initial slope 
estimates. This requirement highlights an advantage of using binary 
response data (which are constrained between 0 and 100% effects), 
where this condition would normally be met. Having a similar shape 
of the dose–response is in accord with a classic understanding of the 
CA model, whereby such agents are mutually exclusive and share 
the same binding site(s) or molecular target. If the dose–responses 
of any two agents being compared are not parallel, then a single 
number does not accurately describe their relative potency. It is read-
ily apparent that when similar slopes are not observed, the devia-
tions can cause large errors in predictions of the relative potency of 
any two (or more) agents (Villeneuve et al. 2000, Ritz et al. 2006, 
Wagner et al. 2013).
Regardless of whether the CA or RA additivity model is used for 
insecticidal protein interaction testing, determination of an expected 
response must match the underlying assumptions for the model on 
which it is based. Unfortunately, this point has often been overlooked 
and our review identified this as a concern for the interpretation of 
these datasets in the context of environmental risk assessments. In 
addition, bioassay response variability and other challenges associ-
ated with designing and conducting insect bioassays may have led to 
incorrect conclusions of synergistic interactions among insecticidal 
proteins. Even for experiments where no additivity model is being 
used (e.g., testing for potentiation or simple interaction where one 
component in a mixture has no activity) (Tabashnik 1992, Belden 
et al. 2007, Raybould et al. 2012a, Graser et al. 2017), the experi-
mental design and methodology play an important part in directing 
subsequent conclusions and interpretations. For example, by choos-
ing an experimental approach which seeks to reduce design elements 
that could introduce response variability, one allows more room for 
the inherent insect response heterogeneity. Such inherent variability 
always remains a challenge due to working with living organisms 
(Robertson et al. 1995, Marçon et al. 1999, Da Silva et al. 2016). 
Overall, the most common concern we highlighted in our review 
of publications was the use of the CA model in calculations from a 
single defined effect level without prior confirmation that the com-
bined insecticidal proteins could be considered as mutually exclusive 
substituents for one another (by virtue of a minimal requirement 
that the slope for the dose–response is parallel).
Materials and Methods
Experiment Selection Criteria
Prior review papers were examined and database searches were 
employed to compile the present summary of studies which investi-
gated potential Bacillus thuringiensis Berliner (Bacillales: Bacillaceae) 
(Bt) insecticidal protein interactions. Searches were performed in the 
following databases: Agricola (National Agricultural Library of the 
U.S. Department of Agriculture, USA; worldwide coverage of agri-
culture and related fields since 1970); BIOSIS (Clarivate Analytics 
(United Kingdom) Limited, covering selected US patent and the 
non-patent literature from the bioscience area since 1926); CABA 
(CAB International (United Kingdom), covering the worldwide lit-
erature from all areas of agriculture and related Sciences since 1973); 
HCAPLUS (Chemical Abstracts Service (USA), bibliographic/chem-
ical structure and dictionary databases covering the patent and 
non-patent literature since 1907); Medline (U.S. National Library 
of Medicine, covering the worldwide biomedical literature since 
1946). Various combinations of truncated keywords and classifica-
tion codes were used in comprehensive search strategies for retrieval 
from the aforementioned databases:
The word stems cry, vip, or cyt were searched in combinations 
of two allowing at least five words between the stems, that is, cry 
within five words of vip, cry within five words or cyt, vip within 
five words of cyt. In an alternative approach, the word stems were 
searched separately.
Both answer sets were further specified for different combina-
tions of concepts applying keywords and synonyms in truncated 
form: synergy/interaction, in vitro/bioassay, mixture/combination.
Experiments Summarized Included Only Those Which:
- were from peer-reviewed articles and published in English;
- made comparisons using either purified proteins (e.g., studies 
that used cell lysates/sporulated cultures are not included) or 
used transgenic event material as a source for the insecticidal 
protein comparisons, but also included information on the pro-
tein expression or quantification;
- used native or engineered versions of Cry1, Cry2, Cry3, Cry9, or 
Vip3A insecticidal proteins.
In general, for studies where more than one insecticidal protein com-
bination was investigated, all the insecticidal proteins used for a re-
spective species are listed together to conserve table space. Individual 
experimental combinations within the same reference were only cap-
tured on a separate line entry if the level of synergy reported or par-
ticular comments warranted (e.g., for future discussion). All studies 
used a mortality parameter unless otherwise noted.
Additionally, experiments were excluded from our review 
summary if:
- interactions of binary toxins (with or without other insecticidal 
proteins) were examined;
- the proteins examined were primarily mosquitocidal toxins (e.g., 
Bt cytolysins, Bin toxins, Mtx toxins, Cry4, Cry10, Cry11);
- resistant strain insects were used as a test organism;
- some other non-insect invertebrate was used as a test organism;
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- the study design did not permit the possible detection of synergis-
tic interaction (e.g., mortality was very high for the concentration 
of individual proteins used, therefore, unreliable for ruling out 
synergy)
Results
We identified a total of 179 interaction experiment results which 
met the acceptance criteria to be included in our summary. A large 
majority of tests (66% of 179) concluded an additive or less than 
additive result (Table 2, Fig. 1) for the insecticidal protein combi-
nations. Following the guidance of requiring a more than twofold 
result as a threshold prior to a conclusion of synergistic interaction 
(Belden et al. 2007, Cedergreen 2014, Rodea-Palomares et al. 2015), 
84% of the test results (151 out of 179) can be described as not more 
than additive. Of the 61 tests where authors originally concluded a 
greater than additive result (Table 3), 46% were estimated at more 
than twofold; 34% at more than threefold; and only two tests (3% 
of 61) were originally described as having an interaction at >10-fold 
over additivity (Table 3, Fig. 1). Importantly, a number of the stud-
ies we examined, including the latter two reports of an interaction 
at >10-fold over additivity, possessed deviations from the model 
assumptions or other methodological concerns which render the ori-
ginal interpretations of a synergistic interaction as problematic.
Discussion
What is the Likely True Incidence of Synergism 
Among Non-Binary Cry and Vip Insecticidal Proteins 
in Currently Registered Transgenic Crops?
In general, the literature strongly supports that synergistic interac-
tions are rarely found between Cry1, Cry2, Cry3, Cry9, and Vip3A 
insecticidal proteins, and specifically, that resultant supra-additive 
interactions are unlikely to occur for cross-class protein mixtures 
where the activity spectra do not overlap (Raybould et al. 2012a, de 
Schrijver et al. 2015, Graser et al. 2017). A 2009 U.S. EPA Scientific 
Advisory Panel observed that ‘with respect to Cry1 and Cry3 pro-
teins used in Bt crops, given their proven safety record, unless a 
greater than 10-fold degree of synergism is observed, there would 
seem to be no need to test for human health or non-target effects’ 
(U.S. EPA 2009b). A review of the data continues to suggest that the 
hypothesis of no interaction has been tested and corroborated suf-
ficiently with respect to Cry1 and Cry3 proteins for the purposes of 
risk assessment.
A close inspection of the literature which does assert that syn-
ergistic interactions exist (for Cry1, Cry2, Cry3, Cry9, and Vip3A 
insecticidal proteins) led to three recurrent findings, regardless of the 
insect species tested: i) the degree of synergistic interaction reported 
is low in magnitude (97% of tests reported less than a 10-fold in-
crease in activity, ~66% reported less than a threefold increase); ii) 
the reported interactions are sometimes equivocal/inconclusive due 
to underlying model assumptions not being confirmed or other bio-
assay limitations/challenges (e.g., protein not purified or status un-
determined, potential for saprophagy, non-binary response metric 
used) (Notably, this is true for the only four reported examples that 
asserted a fivefold or more degree of synergy.); iii) given the demon-
strated variation in biological response across individuals within a 
given study (e.g., the majority of probit estimates had well over a 
1.5-fold 95% CI spread), many of the reported interactions may be 
artifactual (54% of tests reported less than a twofold increase over 
the predicted value).
What is a Suitable Model for Additivity Testing of 
Insecticidal Proteins?
Both the CA and the RA additivity models have been applied across 
different fields of biology and likewise, within entomology, both 
have been used to examine the potential for interaction of insecti-
cidal proteins. Our review shows, however, that for testing of in-
secticidal protein interactions many labs have adopted the CA model 
by virtue of following a methodology outlined by a single publica-
tion where the expected LD50 response is calculated as the harmonic 
mean of the component LD50s (Tabashnik 1992). While this work 
gave sound and much-needed guidance, the calculations therein were 
built on a stated premise that the CA model was ‘most appropriate 
for testing synergism of chemically similar poisons such as B. thur-
ingiensis toxins.’ An understanding of insecticidal protein MoA is 
far from complete, but it has progressed substantially since 1992, 
and although similar in the sense of being membrane-active, clearly 
a number of insecticidal proteins have very different molecular tar-
gets and steps in their MoA. This is particularly relevant for cer-
tain insecticidal proteins (e.g., Vip3A, Lee et al. 2003) that were not 
even identified at the time of the Tabashnik (1992) reference; in add-
ition, a number of other Cry proteins had been identified but not yet 
cloned and purified for in vitro studies at that early date. In other 
fields of biology, restricting the use of the CA model to agents which 
have been demonstrated to be mutually exclusive in their action is 
a bit more consistent, but not perfect (Wagner et  al. 2013, Geary 
2013); likely the complexity of Bt insecticidal protein MoA has hin-
dered applying a similar restrictive principle for use of the CA model 
within entomology.
As described by Groten et al. (2001), an empirical approach to 
assessing compound interactions would be outcome-based, where 
only information regarding the doses/concentration and corre-
sponding effects are available. In contrast, a mechanistic approach 
can take into account more information about known reaction steps 
which have established quantitative relationships (e.g., following 
Michaelis–Menten kinetics) (Groten et al. 2001). We advocate the 
use of a hybrid approach between a strictly empirical versus strictly 
mechanistic view, in that if the insecticidal proteins have demon-
strated non-competitive binding for the receptor(s) (equivalent to 
molecular target sites), this is interpreted in line with the proteins 
having discrete modes of action. This judgment about the existence 
of a discrete MoA (or not) is then taken into consideration for model 
selection and guides how the potential interactions will be examined 
in the ensuing experiments.
It is interesting that both the CA and RA models can often yield 
similar results (Liao et al. 2002, Gennings et al. 2005, Price 2010), 
and furthermore, a comparison of the two models concluded that 
neither one can be selected/preferred just based on inherent accuracy 
(Cedergreen et al. 2008). It should be acknowledged that in actual 
practice, both additivity models are imperfect and that there are iden-
tifiable flaws in each model. For example, with the CA model, dif-
ferential metabolic activity affecting two agents (otherwise identified 
as having the same MoA) and/or differential access to a presumed 
identical binding site could affect the actual shape/sigmoidicity of 
the dose–response curve. These steps can be difficult to parse out, 
resulting in uncertainty regarding the validity of underlying identical 
binding and mechanism of toxicity assumptions (Berenbaum 1989, 
Ritz et al. 2006). Accurately estimating the dose–response curve and 
demonstrating that any two curves should be considered equivalent 
is, therefore, a practical limitation for use of the CA model (Ritz 
et  al. 2006, Foucquier and Guedj 2015), and can warrant a large 
prerequisite dataset. On the other hand, conceptually for the RA 
model, one wonders whether two toxicological agents can really be 
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considered as having no bearing on the action of each other, given 
the complexities of in vivo physiology which exist. To put it another 
way, after an initial agent has already acted on a membrane, cell, or 
tissue, can that site really be considered as unaltered for a second 
agent that approaches and acts ‘independently’ (Cedergreen et  al. 
2008)? Perhaps related to this, when evaluating interactions for Bt 
insecticidal proteins that are being combined for resistance manage-
ment purposes against the same target pest, an effect that is more 
than additive might be best interpreted as an additional interaction 
or downstream effect at the susceptible pest membrane or tissue 
level rather than a protein–protein interaction at a common receptor 
(agonist-like). Even with these conceptual challenges, the RA model 
is capable of providing convincing evidence for more than additive 
effects, resulting from a combination of agents (Foucquier and Guedj 
2015). Also, the existence of ‘imperfections’ for these models due to 
underlying biological complexities is not unique to applications for 
insecticidal protein interaction testing (Berthoud 2013).
Some have concluded that all additive predictive-type models 
should be abandoned when evaluating combinations of agents, in 
deference to simpler, direct comparisons of statistically significant 
increases over the effect of either agent. It is noted that this might 
help to focus attention on the largest interactions (which would 
be most useful from a discovery or research standpoint), and has 
been advocated for registering drug combinations as well as for 
understanding endocrinological interactions (Berthoud 2013, Geary 
2013). In the context of environmental risk assessment, such a shift 
could simplify the testing requirements but may not actually be help-
ful toward understanding any biological significance to the organ-
ism(s) in question. More importantly, demonstration of a statistically 
significant increase in an effect (for a combination of agents) would 
not help determine if an acceptable margin of exposure is in place, 
assuming an actual route of exposure and likelihood of exposure to 
the combination of proteins could be first estimated. The idea that 
‘all models are wrong, but some are useful’ (attributed to Box 1979) 
definitely seems appropriate here, and we advocate that the additiv-
ity models remain useful as assessment tools when applied to robust 
datasets and when the underlying model assumptions are properly 
taken into account and used in the testing strategy.
Recommendations for Improving the Accuracy of 
Synergism Testing
Somewhat related to the concerns mentioned in the earlier sec-
tion for the CA and RA additivity models, there has been criticism 
regarding inaccuracy of both models as they do not follow a ‘sham 
combination’ test. This is illustrated nicely in Foucquier and Guedj 
(2015), where it can be seen that both RA and CA models conclude 
synergism more often than a sham control experiment would sup-
port. But in actual usage (from the standpoint of risk assessment) 
this provides a ‘built-in’ conservative element, with the RA model 
being even a bit more conservative in this way. Also when working 
within the linear range of a dose–response (e.g., between 20 and 
80% mortality for datasets with a full dose–response that achieve 
above 90% corrected mortality), a sham experiment would not gen-
erate a much higher than expected response, so this blanket criticism 
is overstated. The guidance to avoid use of the RA additivity model 
when working in the region of threshold doses (Berthoud 2013), 
however, remains warranted. Importantly, an appropriately designed 
interaction study bioassay will never systematically underestimate 
the existence of a synergistic interaction, irrespective of which addi-
tivity model (or none at all) may be used in the experimental design.
The CA model has a basic assumption that one insecticidal pro-
tein can substitute for another in terms of describing and quantitat-
ing a biological response (Berenbaum 1989, Villeneuve et al. 2000, 
Tallarida 2001, Cedergreen et  al. 2008, Gennings 2010). The RA 
model has a basic assumption that the agents are tested at a dose 
which exhibits toxicity, and that the agents can be expected to work 
through different molecular targets. While the appropriate dose for 
testing can be reliably determined, establishing a sufficient under-
standing about the molecular targets can sometimes prove challeng-
ing (Vachon et al. 2012, Pardo-Lopez et al. 2013, Adang et al. 2014). 
If the CA model is used, however, when in fact an understanding of 
the MoA has progressed enough to demonstrate that the proteins 
differ in an aspect of the MoA which is known to be critical to toxic-
ity (e.g., binding to different target receptors), there is a risk of weak-
ening the experimental interpretations. If an additional fundamental 
mathematical relation assumption for the CA model is violated (fail-
ing to demonstrate that the dose–response slopes are equivalent), 
then the ‘predicted’ effects are clearly not accurate, rendering the 
downstream interpretations of interaction unsound and unreliable. 
Avoiding these prediction errors is directly relevant to determination 
of an expected response using the Tabashnik (1992) equation for the 
CA model (i.e., the harmonic mean calculation, which is based on 
a parallel slope assumption), even for a ray-type design (Gennings 
et al. 2005), where several of the dose combinations would not be 
near the median lethal point. This type of prediction error was the 
most common data concern we identified in our summary of inter-
action tests which concluded a synergistic interaction for insecticidal 
proteins.
Future studies which examine the potential for interac-
tion among insecticidal proteins should benefit from the fol-
lowing considerations to allow for the most meaningful data 
interpretations:
- judge if discrete modes of action exist for the insecticidal proteins 
to be tested;
o consider what is known about the MoA and harmonize this 
understanding with how the combination may be imple-
mented for resistance management purposes;
- use purified protein for the simplest and most robust study 
designs;
- avoid using multiple test organisms per well or container as the 
potential for saprophagy arises, which may allow some organ-
isms to escape the treatment;
- avoid methods which may introduce heterogeneity across the 
testing surface or dosing step (e.g., leaf dip or force-feeding/drop-
let-feeding) when other alternative methods are available;
Fig. 1. Reported interaction testing results (original description of ≤ additivity, 
or degree of supra-additivity) for Cry1, Cry2, Cry3, Cry9, and Vip3A insecticidal 
proteins.
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- if using the CA model to apply the defined LD50 effect level in 
the Tabashnik (1992) harmonic mean equation, demonstrate that 
the parallel slope assumption is valid for the components of the 
testing mixture;
- generate dose–response curves or targeted level positive control 
responses for the individual components concurrently with that 
of the testing mixture;
- avoid using either additivity model in the range of sublethal 
doses (for a mortality metric) or threshold responses (for any 
biological response metric);
o if using a sublethal dose of any component (essentially test-
ing for potentiation of an active component), include a stat-
istical measure of the difference between the observed versus 
the expected response;
- avoid using either additivity model with two components of 
widely differing potency (somewhat related to the above point);
- work from datasets which pass heterogeneity tests for the under-
lying biological response metric;
- for probit analyses, work from datasets which demonstrate a full 
range of responses and with reduced variability
Implications of our Findings for Ecological Risk 
Assessment of GM Insecticidal Protein Stacks
An understanding of the potential for a synergistic interaction is 
helpful during risk assessment to guide inferences from existing eco-
toxicological data (already generated for the trait proteins being 
assessed in the new combination). In actuality, if an interaction study 
result suggests that synergism exists, it is not necessarily indicative 
of a new hazard to NTOs (i.e., it is very unlikely that a new MoA 
will be created from the new combination), it simply indicates that 
the assumption of additivity of the risk (at constant exposure) may 
be unreliable. This would be especially relevant if working with crop 
events that produce substances with concentrations near the NOECs.
Overall, the findings of this present review support the previously 
stated conclusion that there is no a priori concern that a new highly 
active toxin could be created through the combination of these 
well-investigated insecticidal proteins (U.S. EPA 2005). This is rein-
forced by the risk assessment assumption that any interaction which 
may be observed in the sensitive test organism can be applied to the 
assessment of potential impact on NTOs which have already been 
demonstrated to be insensitive to the insecticidal proteins being used 
in the newly tested combination. That is, in most cases, an actual 
NOEC cannot even be established for the NTOs, or the concentra-
tion which exists in the crop is << the NOEC. If a requirement to 
assess the ecological risk of a protein combination has been pre-de-
termined (e.g., in some cases it may be deemed unnecessary), then 
the interaction testing strategy fits into a tiered testing scheme for 
that subsequent risk assessment (Raybould et al. 2012b). It is impor-
tant to note that an alternative strategy to inform the risk assessment 
might involve first tier ecotoxicological testing of the actual protein 
mixture (Raybould et al. 2012b). Following the interaction testing 
strategy, if data are available to corroborate the hypothesis that 
the toxicity of the insecticidal proteins in the transgenic crop is no 
greater when the traits are combined (than when the traits are sepa-
rate) (Fig. 2), the risk can be assessed based on the ecotoxicological 
data available for the single proteins and it follows that previously 
established margins of exposure for the traits alone are applicable 
to the traits in the new combination (reviewed in Raybould et al. 
2012a). Furthermore, a quantitative consideration of any poten-
tial impact of a given interaction must also be kept in the proper 
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route of exposure or the actual margins of exposure (Raybould et al. 
2012a). And if the above hypothesis (that the toxicity of the insec-
ticidal proteins in the transgenic crop is no greater when the traits 
are combined than when the traits are separate) is not corroborated, 
one must still assess whether the increase in toxicity is sufficient 
to require further information on non-target effects to adequately 
assess risk (Fig. 2). If more information is deemed as being required, 
then the assessment of the effects of the mixture of proteins directly 
on one or more non-target organisms could ensue, using taxonomic 
relatedness to the species in which synergism was detected as a useful 
NTO selection criterion (Raybould et al. 2012a).
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